Investing in
Technology Projects
Exhibiting
High Growth Potential
About Us
Our name reflects a core belief inspired by legendary investor Bill Gross: "Timing is the single most important factor in startup success".
Our name reflects a core belief inspired by legendary investor Bill Gross: timing is the single most important factor in startup success.
We invest primarily in pre-seed and seed-stage companies with validated technology, early market traction and valuations generally below $5 million. While we do not always lead rounds, we are prepared to move early and write the first cheque when we identify a compelling opportunity.
Who we work with
Intempo Ventures has completed two successful exits and built a portfolio of more than ten companies across Israel and Barcelona, Spain. We combine disciplined early-stage investing with follow-on capital, active board participation and strategic support to help portfolio companies scale and create long-term value.
We partner with ambitious entrepreneurs building category-leading companies. We focus on early-stage technology businesses addressing large markets with simple, effective solutions to complex problems—and entering those markets at the right time.
Our main areas of interest are:
-
MedTech: medical devices
-
DeepTech: photonics
-
AI: governance infrastructure and robotics
-
FinTech: e-commerce payments
We seek exceptional, complementary teams with a defensible technological advantage, early traction, a scalable business model and a clear path toward product validation and product–market fit.
Intempo Ventures co-invests with selected business angels, family offices and leading venture capital firms.
For further details on our investment process and level of involvement, please contact us.
Key investment criteria guiding our risk assessment
Technology Readiness & Performance Advantage
Product maturity and measurable superiority over existing solutions
CEO, Team
& Road Map
Leadership quality, team capabilities and credibility of the execution plan
Customer
Validation
Evidence that customers need, test or pay for the solution
Capital
Intensity
Funding required to reach commercialization and profitability
Regulatory & Compliance Readiness
Preparedness to meet legal, regulatory and industry requirements
Our Portfolio
Time is Brain is a technology-based start-up founded by KOL neurologists with expertise in cerebrovascular diseases.
The team has brought innovative solutions to ameliorate the impact that strokes have on patients and their families. Time is Brain is developing a medical device to implement N20 in the entire stroke patient journey aiming to decrease the patient’s disability.
MedTech | Medical Device
Ark Surgical is commercializing LapBox™, a simple-to-use tissue containment system for secure removal of large internal organs during laparoscopic surgery.
LapBox is the next-generation containment system that enables the use of power and manual morcellation with minimal risk and allows patients and surgeons to benefit from laparoscopic procedures instead of open surgery.
MedTech | Medical Device
Adshir’s LocalRay™ software is a Ray Tracing Graphics Engine scaling from High-End Gaming GPUs to mobile devices. LocalRay™ is the first Real-Time Ray Tracing solution for battery-powered devices. It is a software-based engine, hardware-independent, and cross-vendor technology.
DeepTech | Exit to SNAP
With BIGVU anyone can create professional videos quickly with just their smartphone and without video editing skills.
BIGVU is a TV studio in your pocket: teleprompter, automatic captions, branding with logo & motion titling, intros & outros. The company has a growing audience of more than 2.5 million users in over 70 countries.
MediaTech | Teleprompter
DormoTech Medical provides sleep tests with a High-quality as sleep clinic and Maximum comfort at home. DormoTech’s patented and FDA-cleared DormoVision X™ is a wireless, cloud-based platform that records 38 physiological channels for comfortable, multi-night sleep studies at home, with clinical-grade accuracy for patients aged six years and older.
MedTech | Medical Device
A global clinical-stage biopharma company developing locally administered therapies to improve surgical outcomes. Its proprietary PLEX platform enables controlled, long-term drug delivery directly at the surgical site, targeting infections, pain, inflammation, and cancer. Its lead focus is Surgical Site Infections (SSIs),a major healthcare burden and a priority public-health challenge identified by the FDA, particularly due to antibiotic resistance.
MedTech | Biopharma
The first patented Edge AI infrastructure that replaces 5-8 hotel cloud vendors with one offline, regulation-ready system. Starting with hospitality, the same patented architecture applies to any regulated industry whether it be finance, healthcare, or government, where AI decisions require tamper-proof, court-admissible evidence.
DeepTech | Autonomous Compliance AI Infrastructure
Deep Detection’s advanced photon-counting sensors combine high-performance capabilities into a single, highly versatile camera designed for in-line inspection across industrial and security applications. Unmatched sensitivity and ultra-low noise deliver superior contrast imaging, enabling reliable detection of even the lightest-weight materials.
DeepTech | Photonic Inspection
The Leading Team
Olivier Resnik
Founder, Managing Partner
Olivier founded Intempo Ventures after building a successful track record across several sectors. Investor in commodities, public equities, and start-ups, he has leveraged his experience to establish Intempo Ventures, focusing exclusively on early-stage companies.
